According to Zomedica Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$0.02300. In 2022 the company made an earnings per share (EPS) of -$0.02000 an increase over its 2021 EPS that were of -$0.05100.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.02300 | 15% |
2022 | -$0.02000 | -60.78% |
2021 | -$0.05100 | -9.73% |
2020 | -$0.05650 | -71.75% |
2019 | -$0.20 | 17.65% |
2018 | -$0.17 | 88.89% |
2017 | -$0.09000 | 32.45% |
2016 | -$0.06795 | 91.04% |
2015 | -$0.03557 | 185.72% |
2014 | -$0.01245 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | 9,378.26% | ๐บ๐ธ USA |